Who will benefit from psychedelic medicine? | Curio

Who will benefit from psychedelic medicine?

33 mins | Sep 30, 2020

The troubles of accessibility are already present. MDMA-assisted psychotherapy is a turning point in the mainstreaming of psychedelics. These substances are being touted as a game-changing intervention for mental health. Whitney Joiner investigates the promise that this treatment could be accessible to all.

publisher logo

From The Washington Post

Read along